Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients.

Wilma E. Mesker(Leiden University Medical Center), Hans J. Tanke(Leiden University Medical Center), Gerrit‐Jan Liefers(Leiden University Medical Center), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Noel F. de Miranda(Leiden University Medical Center), Karin A. M. van Leeuwen(Rijnland Ziekenhuis), Peter J.K. Kuppen(Leiden University Medical Center), Károly Szuhai(Leiden University Medical Center), Hans Morreau(Leiden University Medical Center), Paola Alberici(Erasmus MC), Jan M. C. Junggeburt(Leiden University Medical Center), Gabi W. van Pelt
PubMed
January 1, 2009
Cited by 131


Related Papers